CTD-M 6.25/25 Tablet ER

Overview CTD-M 6.25/25 Tablet ER

The extended-release CTD-M 6.25/25 mg tablet is indicated for managing hypertension (high blood pressure) when monotherapy proves insufficient. This medication aids in blood pressure control, reducing the risk of future strokes and heart attacks. Early administration improves cardiac arrest survival rates. CTD-M 6.25/25 mg tablets are best taken once daily, preferably in the morning, with or without food, to minimize nocturnal urination. Continue treatment as prescribed; discontinuation, even with symptom absence, can worsen hypertension, often asymptomatic. Lifestyle modifications including regular exercise, weight management, and a balanced diet complement the medication's effects. Closely follow your physician's instructions. Common side effects include nausea, constipation, diarrhea, and tiredness. Report persistent, worsening, or bothersome side effects to your doctor promptly. Increased fluid intake may alleviate symptoms like muscle weakness, dry mouth, and thirst. Initial dizziness or headaches, potentially due to lowered blood pressure, usually subside. Prior to initiating treatment, inform your physician of any kidney or liver conditions, pregnancy, breastfeeding, or concurrent medications, particularly those for hypertension or cardiac issues. Regular monitoring of blood pressure, kidney function, blood glucose, and electrolyte levels (potassium, magnesium) is crucial to ensure therapeutic efficacy.

Uses of CTD-M 6.25/25 Tablet ER

Elevated blood pressure

Major Benefits of CTD-M 6.25/25 Tablet ER:

Administer this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The CTD-M 6.25/25 Extended-Release tablet can be consumed with or without food, though consistent timing is recommended.

Common Side effects of CTD-M 6.25/25 Tablet ER:

• Nausea
• Constipation
• Diarrhea
• Fatigue
• Headache
• Dizziness
• Slow heart rate
• Increased blood uric acid
• Decreased potassium level in blood
• Glucose intolerance
• Altered blood lipid level
• Cold extremities
• Decreased magnesium level in blood
• Increased calcium level in blood

How to use CTD-M 6.25/25 Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the CTD-M 6.25/25 Tablet ER whole; do not break, crush, or chew it. This extended-release tablet can be taken with or without food, though consistent timing is recommended.

How CTD-M 6.25/25 Tablet ER works:

Each CTD-M 6.25/25 Extended-Release tablet unites Metoprolol Succinate and Chlorthalidone, two agents that decrease blood pressure. Metoprolol Succinate, a beta-blocker, acts directly on the heart, slowing its rate and enhancing its pumping efficiency. Chlorthalidone, a diuretic, reduces blood pressure by eliminating excess fluid and electrolytes, while concurrently promoting vasodilation and improved circulation.

What if you forget to take CTD-M 6.25/25 Tablet ER :

Should you forget to take a CTD-M 6.25/25 Tablet ER, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.